Results of a prospective cohort study suggest history of gestational diabetes (GD) may promote development of atherosclerotic plaque, potentially increasing the risk of future heart disease among ...
GlobalData on MSN
FDA grants accelerated approval for Otsuka’s IgAN therapy
Otsuka Pharmaceutical has accelerated FDA approval for Voyxact to reduce proteinuria in adults with primary IgAN at disease ...
Barchart on MSN
Is General Dynamics Stock Outperforming the Nasdaq?
While General Dynamics has surged past the Nasdaq Composite in 2025, it has slightly lagged behind the index recently.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する